Cargando…
Antithrombotic Strategy for Patients with Acute Coronary Syndrome: A Perspective from East Asia
Dual antiplatelet therapy (DAPT) after percutaneous coronary intervention has become the standard of care, particularly in patients with acute coronary syndrome (ACS). Current clinical guidelines recommend novel P2Y12 inhibitors (e.g., prasugrel or ticagrelor) in addition to aspirin based on the res...
Autores principales: | Numasawa, Yohei, Sawano, Mitsuaki, Fukuoka, Ryoma, Ejiri, Kentaro, Kuno, Toshiki, Shoji, Satoshi, Kohsaka, Shun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356748/ https://www.ncbi.nlm.nih.gov/pubmed/32585929 http://dx.doi.org/10.3390/jcm9061963 |
Ejemplares similares
-
Association of Second-Generation Drug-Eluting Stent Length With 2-Year Adverse Clinical Outcomes Among Japanese Patients With Ischemic Heart Disease
por: Ejiri, Kentaro, et al.
Publicado: (2020) -
Outcomes of acute coronary syndrome patients with concurrent extra-cardiac vascular disease in the era of transradial coronary intervention: A retrospective multicenter cohort study
por: Kodaira, Masaki, et al.
Publicado: (2019) -
Long-term outcomes of periprocedural coronary dissection and perforation for patients undergoing percutaneous coronary intervention in a Japanese multicenter registry
por: Kuno, Toshiki, et al.
Publicado: (2023) -
Contrast volume and in-hospital outcomes of dialysis patients undergoing percutaneous coronary intervention
por: Kuno, Toshiki, et al.
Publicado: (2022) -
Effects of body habitus on contrast-induced acute kidney injury after percutaneous coronary intervention
por: Kuno, Toshiki, et al.
Publicado: (2018)